CVS Health Qtrly Revenue Rose 10.1% to $76.6 Billion.
CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2021 RESULTS, CONFIRMS 2022 FULL-YEAR EPS GUIDANCE.
QTRLY TOTAL REVENUES INCREASED TO $76.6 BILLION, UP 10.1% COMPARED TO PRIOR YEAR.
QTRLY GAAP DILUTED EPS FROM CONTINUING OPERATIONS OF $0.98 AND ADJUSTED EPS OF $1.98.
REVISED CASH FLOW FROM OPERATIONS GUIDANCE RANGE TO $12.0 BILLION TO $13.0 BILLION FROM $12.5 BILLION TO $13.0 BILLION.
STORE IMPAIRMENT CHARGE OF APPROXIMATELY $1.4 BILLION RECORDED IN Q4 OF 2021.
QTRLY RETAIL/LTC SEGMENT TOTAL SAME STORE SALES ROSE13.4%.
QTRLY RETAIL/LTC SEGMENT SAME STORE SALES FOR PHARMACY ROSE 11.8%.
ADMINISTERED MORE THAN 8 MILLION COVID-19 TESTS AND MORE THAN 20 MILLION COVID-19 VACCINES NATIONWIDE IN Q4 OF 2021.
FOR FULL YEAR, COMPANY ADMINISTERED MORE THAN 32 MILLION COVID-19 TESTS.
ANNOUNCED A SIGNIFICANT INVESTMENT IN ITS EMPLOYEES BY RAISING MINIMUM ENTERPRISE HOURLY WAGE TO $15.00 AN HOUR EFFECTIVE JULY 2022.
